Characterization of moclobemide N-oxidation in human liver microsomes.
about
Substrates of human cytochromes P450 from families CYP1 and CYP2: analysis of enzyme selectivity and metabolism.Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers.Investigation of enzyme selectivity in the human CYP2C subfamily: homology modelling of CYP2C8, CYP2C9 and CYP2C19 from the CYP2C5 crystallographic template.Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale.
P2860
Characterization of moclobemide N-oxidation in human liver microsomes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Characterization of moclobemide N-oxidation in human liver microsomes.
@en
Characterization of moclobemide N-oxidation in human liver microsomes.
@nl
type
label
Characterization of moclobemide N-oxidation in human liver microsomes.
@en
Characterization of moclobemide N-oxidation in human liver microsomes.
@nl
prefLabel
Characterization of moclobemide N-oxidation in human liver microsomes.
@en
Characterization of moclobemide N-oxidation in human liver microsomes.
@nl
P2093
P2860
P1433
P1476
Characterization of moclobemide N-oxidation in human liver microsomes.
@en
P2093
P2860
P304
P356
10.1080/00498250110055488
P407
P577
2001-07-01T00:00:00Z